CRSP CapEx to Revenue
Crispr Therapeutics Ag · CapEx to Revenue
CRSP CapEx to Revenue
Current (TTM)31.48%retrieved
CRSP CapEx/Revenue (0.00% → 31.48%)
Latest values, visible window
High-resolution chart · PNG
CRSP capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 26.0399% | |
| 5.4314% | |
| 2.5595% | |
| 8,529.3578% | |
| 8.9483% | |
| 2,553.2684% | |
| 2.3081% | |
| 88.7644% | |
| 19.0599% | |
| 58.4043% | |
| 467.2065% | |
| 0% |